LY4256984

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY4256984, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis [Phase 1]